High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximab

2016 ◽  
Vol 19 (6) ◽  
pp. 718-726 ◽  
Author(s):  
S. S. Kumar ◽  
Y. Tomita ◽  
J. Wrin ◽  
M. Bruhn ◽  
A. Swalling ◽  
...  
Oncotarget ◽  
2015 ◽  
Vol 6 (37) ◽  
pp. 39941-39959 ◽  
Author(s):  
Konstantinos Stamatakis ◽  
Marta Jimenez-Martinez ◽  
Alba Jimenez-Segovia ◽  
Isabel Chico-Calero ◽  
Elisa Conde ◽  
...  

2004 ◽  
Vol 72 (6) ◽  
pp. 3549-3560 ◽  
Author(s):  
M. M. M. Abdel-Latif ◽  
H. J. Windle ◽  
K. A. Fitzgerald ◽  
Y. S. Ang ◽  
D. Ní Eidhin ◽  
...  

ABSTRACT The early growth response 1 (Egr-1) transcription factor is rapidly induced by various stimuli and is implicated in the regulation of cell growth, differentiation, and gene expression. The aim of this study was to examine the effect of Helicobacter pylori on the expression of Egr-1 and Egr-1-regulated genes in gastric epithelial AGS cells. Egr-1 expression was assayed by immunoblotting and electrophoretic mobility shift assays using H. pylori-stimulated AGS cells. Transient transfection experiments with promoter-reporter constructs of CD44, ICAM-1, and CD95L were used for expression studies. H. pylori induced the expression of Egr-1 in gastric epithelial cell lines in a dose-dependent manner, with the rapid kinetics that are typical of this class of transcription factors. Immunohistochemical studies of biopsies revealed that Egr-1 expression is more abundant in H. pylori-positive patients than in uninfected individuals. Reporter-promoter transfection studies indicated that Egr-1 binding is required for the H. pylori-induced transcriptional promoter activity of the CD44, ICAM-1, and CD95L (APO-1/Fas) constructs. The blocking of egr-1 with an antisense sequence prevented H. pylori-induced Egr-1 and CD44 protein expression. The MEK1/2 signaling cascade participates in H. pylori-mediated Egr-1 expression, but the p38 pathway does not. The data indicate that H. pylori induces Egr-1 expression in AGS cells in vitro and that the Egr-1 protein is readily detectable in biopsies from H. pylori-positive subjects. These observations suggest that H. pylori-associated Egr-1 expression may play a role, in part, in H. pylori-induced pathology.


2005 ◽  
Vol 65 (12) ◽  
pp. 5133-5143 ◽  
Author(s):  
Anja Krones-Herzig ◽  
Shalu Mittal ◽  
Kelly Yule ◽  
Hongyan Liang ◽  
Chris English ◽  
...  

2013 ◽  
Vol 31 (2) ◽  
pp. 788-794 ◽  
Author(s):  
DAE-SEONG MYUNG ◽  
YOUNG-LAN PARK ◽  
NURI KIM ◽  
CHO-YUN CHUNG ◽  
HYUNG-CHUL PARK ◽  
...  

2019 ◽  
Vol 20 (17) ◽  
pp. 1179-1187
Author(s):  
Adrien Labriet ◽  
Éric Lévesque ◽  
Elena De Mattia ◽  
Erika Cecchin ◽  
Derek Jonker ◽  
...  

Aim: Germline variants could modify survival of metastatic colorectal cancer patients (mCRC). Patients & methods: The association of 285 haplotype-tagging SNPs in 11 candidate genes and overall survival (OS) was tested in two cohorts totalizing 417 FOLFIRI-treated mCRC. Gene expression was investigated in vitro and in public datasets. Results: In the combined cohort, CES1 rs9921399T>C was associated with prolonged OS (hazard ratio [HR] = 0.40) whereas ABCC1 rs17501011G>A (HR = 2.08) and UGT1 rs1113193G>A (HR = 2.12) were associated with shorter OS (p ≤ 0.005). A combined effect of these polymorphisms was observed with HR of 1.98–2.97 (p < 0.05). The ABCC1 rs17501011A variant reduced reporter-gene activity (p < 0.05) whereas ABCC1 tumor expression was associated with shorter survival (p ≤ 0.013). Conclusion: We identified a combination of genetic determinants that could predict mCRC survival.


Sign in / Sign up

Export Citation Format

Share Document